Conventional One-Lung Ventilation
OtherVt 10 ml/kg
NCT Number: NCT03056885
This study evaluates the local cytokine inflammatory response during one lung ventilation in patients undergoing pulmonary lobectomy or wedge resection. We compare two different ventilation strategies: a conventional strategy with a protective strategy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
One-lung ventilation (OLV) is a ventilation procedure used for pulmonary resection often causing lung injury. International guidelines have recommended for years the use of conventional ventilation (CV) with high tidal volume (VT) (8-10 ml\\kg).A body of recent evidences have shown that conventional ventilation can reduce systemic oxygenation, increase inflammatory products and cause lung tissue damage. In this study we compare the conventional strategy , consisted of Vt 10 mL/kg, with the protective strategy, consisted of Vt 5 mL/kg. Both Vt were based on predicted body weight (PBW). Broncho-alveolar lavages (BAL) are selectively performed in the dependent (ventilated) lung before and at the end of the OLV. The levels of pro-inflammatory (IL-1α, IL-1β, IL-6, IL-8, TNF) and anti-inflammatory (IL-2, IL-4, IL-10, INFγ) cytokines are evaluated. We also evaluate patients clinical outcomes in terms of incidence of postoperative respiratory complications and length of stay.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vt 10 ml/kg
Vt 5 ml/kg
Time frame: Change from Baseline cytokines level and the end of surgery (about 60 minutes)
The levels of cytokines were evaluated in broncho-alveolar lavage (BAL)
Time frame: within 48 hours of the operation
PaO2 /FIO 2 <300 mm Hg and /or the presence of newly developed lung lesions (lung infi ltration and atelectasis)
Time frame: 1 month
lenght of hospital stay expressed in days
University of Roma La Sapienza
Other
Does a Protective One Lung Ventilation Strategy Reduce the Inflammatory Cytokine Local Response After Pulmonary Resection?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07349719
Bone Diseases, Hernia
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05991258
Acute Respiratory Failure, Lung Diseases
Padua, Italy
View Trial DetailsNCT05125952
Acute Respiratory Failure, Lung Diseases
Durham, North Carolina, United States
View Trial DetailsNCT06413472
Acute Respiratory Distress Syndrome, Lung Diseases
Istanbul, Turkey (Türkiye)
View Trial Details